Sunday, April 15, 2012

“We are lucky to have the sensory abilities of vision,” Changing the color of your eyes “but don’t go asking for trouble”


Lasering the iris to destroy the brown pigment to turn it blue is “probably risky,” Dr. Robert Cykiert, associate professor of ophthalmology at NYU Langone Medical Center, told ABCNews.com.

“When you burn the brown pigment away with a laser, the debris that is created in the front of the eyethink of it as ashes resulting from burning anything — is likely to clog up the microscopic channels in the front of the eye, known as trabecular meshwork,” said Cykiert. “[It] is very likely to cause a high pressure in the eye, known as glaucoma.

In some patients, this high pressure might  be temporary, he said, but in others, it could be permanent. Glaucoma is a disease that can cause serious permanent loss of vision.
Cykiert  also said that burning large amounts of brown pigment is likely to cause inflammation and potential damage to the cornea. The procedure could also bring on cataracts, depending on the severity of the inflammation.

Dr. Ivan Schwab, a professor of ophthalmology at the University of California at Davis School of Medicine and clinical correspondent at the American Academy of Ophthalmology, also has his doubts.

“These risks take time to develop, so they may not develop in the first year or two. It could take five or 10 years,” said Schwab. “If a large number of people were to undergo this procedure of lasering the iris, and it caused these problems down the road, we’d have a major public health problem on our hands.”

Tuesday, April 10, 2012

SEVEN Black Tie Event for CEOs in Life Scienes

SEVEN (Scientific Entrepreneur & Venture Capital Network) Orange County is hosting a Life Science Executive Mixer.- Join on Linkedin.SEVEN
 
The event is a black tie cocktail event starting at 5:30 PM to 9:00PM.
Date: 24 May 2012
Location: Irvine/Newport Beach
Sponsors: Pl contact : Raj at: accessclinicaltrials@gmail.com
There is opportunity to sponsor the event. pl call: 714-658-3039


This event will bring the medical device, pharma, biotech and health care IT entrepreneurs, executives and the investor community together to boost the booming life science industry in Orange County and So Cal.
About 200 Life Science executives, investors and start up entrepreneurs are expected to attend.

SEVEN is screening Medical Device, Biotech, Healthcare IT start up companies that would like to have a table top display/presentation (limited to 20 tabletops only) for an exclusive CEO/Investor Black Tie Event for Life Science companies, pl note few spots are left.  Pl Email to qualify for the event. (Start up with innovative technology, good team, good story)

Pl send your company profile and executive summary to: Raj Nihalani
E: accessclinicaltrials@gmail.com
For Registration/attendance pl contact:  accessclinicaltrials@gmail.com
There is opportunity to sponsor the event. pl call: 714-658-3039


Job Act & Sarbanes-Oxley Compliance

When the time is right, the JOBS Act makes it easier for a new class of "emerging growth companies" to go public.  

Young, high-growth firms are allowed up to five years to comply with certain Sarbanes-Oxley Act disclosures.
The Life Science Sector will boom! with the help of Job Act.
 
Sarbanes-Oxley compliance is much more onerous for smaller companies than it is for larger entities such as General Electric, Johnson & Johnson or IBM. 

The JOBS Act helps smaller companies conserve resources. It also provides an "IPO On-Ramp" during which time emerging growth companies can protect sensitive information and competitive trade secrets.

To protect investors, the JOBS Act includes an amendment that mandates companies to provide basic financial information to investors before seeking crowdfunding. It also requires third-party intermediaries, in the form of websites managing crowdfunding shares, to register with the SEC

The amendment also sets limits on the amount of money an individual can invest to prevent investors from taking too much risk. Individuals with an annual income or net worth of less than $100,000, for example, would be limited to investing 5% of their income in crowdfunding.

In addition, Obama called on the Treasury Department, Small Business Association and Justice Department to monitor the new legislation closely and report regularly on their findings.

Certainly, the JOBS Act is a win for entrepreneurs in America. But it is only a first step. The bill will help innovators reduce burdensome regulation and gain faster access to capital to grow their startup businesses. Immigrants founded or co-founded almost half of the 50 top venture-backed companies in the United States, and on average these companies created 150 jobs.

 Another way is to make open-technology licensing a condition for universities to receive federal research dollars. Currently, the Bayh-Dole Act of 1980 requires faculty innovators to work through their own university technology licensing offices. This creates significant delays.


To catalyze our innovation economy, we need to increase collaboration between startups and larger corporations. One such example is the NYSE Big StartUp initiative that partners large companies with small businesses to provide corporate assistance with accounting support, legal services, marketing infrastructure and financial training. Small companies often lack resources to take their business to scale. Corporate America can help catapult fledgling entrepreneurs to the next level.
America's competitive position in the world will increasingly depend on our entrepreneurs. The JOBS Act provides momentum.